Immuron IMRN
NASDAQ IMRN
$1.24 +0.02 (+1.64%)
At close: Sep 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Cash from Investing Activities (2016 - 2022)

Immuron (IMRN) posted Cash from Investing Activities of -$2.6 million for Q4 2022, down 47009.79% on a QoQ basis from $5550.2 in Q4 2021, and down 47009.79% year-over-year from N/an in Q4 2021.

Analysis

Immuron (IMRN) Cash from Investing Activities (2016 - 2022) Analysis & Trends

Immuron has reported Cash from Investing Activities for 7 years, with the latest figure at -$2.6 million in Q4 2022.

  • On a quarterly basis, Cash from Investing Activities fell 47009.79% year-over-year to -$2.6 million in Q4 2022; TTM through Dec 2022 was -$2.6 million, a 55595.1% decrease from a year earlier, with the FY2026 full-year figure at $3.2 million, up 211.73% from the prior year.
  • Cash from Investing Activities was -$2.6 million for Q4 2022 at Immuron, down from $5550.2 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $5550.2 in Q4 2021, with the low at -$2.6 million in Q4 2022.
  • Average Cash from Investing Activities over 5 years is -$519777.2, with a median of -$301.0 recorded in 2020.
  • The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities jumped 1943.91% in 2021, then sank 47009.79% in 2022.
  • Over 5 years, Cash from Investing Activities stood at $39.0 in 2018, then sank by 1651.28% to -$605.0 in 2019, then surged by 50.25% to -$301.0 in 2020, then surged by 1943.91% to $5550.2 in 2021, then tumbled by 47009.79% to -$2.6 million in 2022.
  • The last three Cash from Investing Activities figures came in at -$2.6 million (Q4 2022), $5550.2 (Q4 2021), and -$301.0 (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -569.00 Mn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -10.35 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -45.80 Mn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -92.70 Mn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 329.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -363.46 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -3.84 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 281.26 Mn
10 Immuron 7.14 Mn -1.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -2.60 Mn
Dec 31, 2021 5,550.16
Dec 31, 2020 -301.00
Dec 31, 2019 -605.00
Dec 31, 2018 39.00
Dec 31, 2017 -1,676.50
Dec 31, 2016 1,416.72
API Access

Immuron Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=IMRN&period=max&api_key=YOUR_API_KEY